Diabetic macular oedema - initial authority application form (PB155)

Use this form to apply for initial PBS-subsidised treatment with aflibercept, dexamethasone intravitreal implants, faricimab or ranibizumab for diabetic macular oedema.

Page last updated: 1 June 2025.
QC 21336